Global Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Neimeth International Pharmaceuticals

Market Cap: ₦26.3b

Manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana.

Imugene

Market Cap: AU$96.2m

A clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.

Faron Pharmaceuticals Oy

Market Cap: UK£187.9m

Operates as a clinical stage drug discovery and development company.

Unité de Fabrication des Médicaments

Market Cap: د.ت284.8m

Unité de Fabrication des Médicaments S.A.

Solid Biosciences

Market Cap: US$462.8m

Develops therapies for neuromuscular and cardiac diseases in the United States.

Phibro Animal Health

Market Cap: US$1.5b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

FibroGen

Market Cap: US$34.8m

A biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.

Innoviva

Market Cap: US$1.5b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

Spyre Therapeutics

Market Cap: US$2.6b

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

ProPhase Labs

Market Cap: US$4.1m

Develops and commercializes novel drugs, dietary supplements, and compounds in the United States.

RAPT Therapeutics

Market Cap: US$936.9m

Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.

BioCryst Pharmaceuticals

Market Cap: US$1.6b

A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.

Eurofins Scientific

Market Cap: €10.9b

Provides various analytical testing and laboratory services worldwide.

Ipsen

Market Cap: €9.9b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide.

Devyser Diagnostics

Market Cap: SEK 1.9b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Agilent Technologies

Market Cap: US$38.8b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Incannex Healthcare

Market Cap: US$151.6m

A clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia.

Emergent BioSolutions

Market Cap: US$652.3m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Senores Pharmaceuticals

Market Cap: ₹37.1b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

Mountain Valley MD Holdings

Market Cap: CA$5.3m

A biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada.

Pyxis Oncology

Market Cap: US$79.4m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

Aclaris Therapeutics

Market Cap: US$340.2m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.

Tiziana Life Sciences

Market Cap: US$180.6m

A biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States.

Disc Medicine

Market Cap: US$3.0b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

BioCardia

Market Cap: US$13.5m

A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.

NovaBridge Biosciences

Market Cap: US$483.1m

A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.

Belite Bio

Market Cap: US$5.9b

A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States.

Xenon Pharmaceuticals

Market Cap: US$3.4b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.

Zura Bio

Market Cap: US$277.6m

A clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States.

InflaRx

Market Cap: US$75.2m

A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.

Arrowhead Pharmaceuticals

Market Cap: US$9.3b

Develops medicines for the treatment of intractable diseases in the United States.

NewAmsterdam Pharma

Market Cap: US$4.0b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.

Assembly Biosciences

Market Cap: US$557.7m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

Senti Biosciences

Market Cap: US$31.5m

A clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.

MiNK Therapeutics

Market Cap: US$54.4m

A clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.